Boston Trust Walden Corp Bio Techne Corp Transaction History

Boston Trust Walden Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$188.72 - $215.43 $9.66 Million - $11 Million	-51,210 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$136.09 - $200.44 $7.81 Million - $11.5 Million	-57,353 Reduced 52.83%	51,210 $10.2 Million
Q4 2018 Jan 17, 2019	SELL	$132.75 - $203.8 $5.32 Million - $8.17 Million	-40,097 Reduced 26.97%	108,563 $15.7 Million
Q3 2018 Oct 23, 2018	SELL	$147.44 - $204.11 $881,691 - $1.22 Million	-5,980 Reduced 3.87%	148,660 $30.3 Million
Q2 2018 Jul 25, 2018	BUY	$144.9 - $165.58 $2.48 Million - $2.83 Million	17,111 Added 12.44%	154,640 $22.9 Million
Q1 2018 Apr 13, 2018	SELL	$131.46 - $151.04 $1.05 Million - $1.21 Million	-8,001 Reduced 5.5%	137,529 $20.8 Million
Q4 2017 Jan 29, 2018	SELL	$121.17 - $134.75 $346,909 - $385,789	-2,863 Reduced 1.93%	145,530 $18.9 Million
Q3 2017 Oct 13, 2017	BUY	$113.59 - $123.78 $16.9 Million - $18.4 Million	148,393	148,393 $17.9 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

Stay updated on Boston Trust Walden Corp with notifications on news.